Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.

ER, Seaquist; H, Dulude; XM, Zhang; R, Rabasa-Lhoret; GM, Tsoukas; JR, Conway; SJ, Weisnagel; G, Gerety; VC, Woo; S, Zhang; D, Carballo; S, Pradhan; CA, Piché; CB, Guzman

doi:10.1111/dom.13278

Public

Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.

Shared by NobleBlocks on Mar 22, 2018 • 12:00 AM UTC

Authors:

Seaquist ER

Dulude H

Zhang XM

Abstract

In the present multicentre, open-label, prospective, phase III study, we evaluated the real-world effectiveness and ease of use of nasal glucagon (NG) in the treatment of moderate/severe hypoglycaemic events (HEs) in adults with type 1 diabetes (T1D). Patients and caregivers were taught how to use N...

Subject

Adults

type 1 diabetes

hypoglycaemia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!